about
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular EventsBiological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast CancerCultured White Cells Plus Interleukin-2 to Treat Advanced Kidney CancerTrial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerTPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck TumorsCombination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric CancerCancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung CancerQUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple MyelomaTumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast CancerCombination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasA Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsRandomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After InterventionsVaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer PatientsBronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerTrial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG ImmunotherapyLeuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate CancerIrradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney CancerHyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerTh1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple MyelomaVaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple MyelomaNeoadjuvant Hormonal Therapy Combined With ChemoimmunotherapyComparing Xperguide vs. Conventional Methods During Percutaneous Image Guided ProceduresPioglitazone Therapy for Chronic Granulomatous DiseaseGeneration of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis SubjectsThe Role of C-HAM in the Surgical Repair of Peroneal Tendons: An Infrared Thermography ModelNon-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care PatientsThe Dutch Asymptomatic Mitral Regurgitation TrialStudy Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy SubjectsBiological Biomarkers in MOMS PartnershipLongitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United StatesfMRI Neurofeedback for Motor RehabilitationECI301 and Radiation for Advanced or Metastatic CancerMuscle Biopsies in Healthy VolunteersUltrasound and Other Images of Artery Blockages
P8005
Q288786-B286B404-C0E0-427B-8B42-92BD09617AB2Q58407405-9403FE2D-35AD-4ED6-9295-4CA9F3493DD9Q58407406-589F74BF-3106-4DC8-A27C-C05E9072812EQ58407436-83EFFD5B-A31E-4E13-B1F1-67CCC1BC03C7Q58407505-4B719DDF-7BD8-4A96-A2CB-AB14E313A292Q58407509-E8F52745-CC34-4C4E-88E3-18FAF644C5DFQ58407514-5B99FDF1-F9EE-4023-9E82-4AA7D1A99A92Q58407515-6FACB776-9DCE-4DD6-87B6-086E3BFB2BB9Q58407526-28552961-C44A-42E5-8323-484958C8BEDEQ58407530-C0BF50A7-7334-4AD9-BA16-F10BF4AFCE9CQ58407538-4EEA265A-7DCE-4E17-AEAD-653021C85A7AQ58407557-2479E53F-4B34-4E65-8138-E8BA6BBCCFC2Q58407583-D25FD23F-CD19-46D7-AC20-6B6126D5844FQ58407598-9E2D6BBB-1551-4F4B-9722-D82582C312FBQ58407758-390EEB8D-2825-4462-9393-D07AE9D5A043Q58844210-3A6A2297-5816-4C24-92F4-98D9DB8BF7E7Q58844210-80610D7F-2F56-4883-8E0E-94B46725AE29Q58844748-3FAC25C3-7742-48D9-ADFD-D3F4B6BF168BQ58844748-CDF6E70E-AA01-4B4D-AB4F-93DAED8F7918Q58845895-391F2884-3B41-4458-BFFF-F44801D37172Q58845895-44F23262-B42C-4B08-8E52-51024812E1FDQ58846247-0141F300-4F49-434D-8C83-0C2827E6793AQ58848645-279251CD-C7B2-4AA9-831A-C5E610A86007Q58849055-C0109C5B-83A3-41B1-8E0A-6BE25B6BB881Q58849083-E6661781-9EF0-4900-9E1E-A336C9DCD87EQ58849392-C8C3E753-E9DD-40D1-9097-7B2DFCC747ABQ58849643-D65DFC24-BD2E-4F3B-B71F-7E7269379A3FQ58849709-0F3E420A-B86B-47B4-83D5-D98DA1A77814Q58849709-3D59CF3D-1E3A-49CD-B2DC-32850120BBD1Q58849726-33C10979-6F84-4F12-ACEB-070AF7D6F13BQ58849726-91952015-2780-4A68-82E8-C1139FF6F17AQ59772552-4122471A-B38C-4957-A342-164A56E2DD07Q60392210-CD2484CA-A194-46C1-B23E-F37E6C8DCD52Q60501338-BAEA097C-3763-4FF6-846F-7824FCD9B1E1Q61707389-7E13CE1F-DA61-4E99-94D7-5662834BE80BQ61707427-B05BA9AF-5F02-4756-ABEF-3ABC82C72342Q61707479-A061BD75-3C7E-4087-89E9-3FB2BF4A0601Q61713147-BFAD646E-CCE1-4C8C-BA3E-A346705F35E2Q61713147-FEE5B54D-2F4F-43E7-851A-AA40528B6B21Q61729736-B06CB026-315A-4F8D-B818-92FF0B90F4E6
P8005
description
recruitment status in clinical trials
@en
name
acabat
@ca
terminated
@en
type
label
acabat
@ca
terminated
@en
prefLabel
acabat
@ca
terminated
@en